PML School
Forum to help write and understand PML
ln-transformed PK parameters in PML codeStarted by LLLi , 18 Mar 2017 |
|
|
||
Materials for running NONMEM and Phoenix NLME in the cloudStarted by bwendt@certara.com , 24 May 2018  NONMEM, NLME, Cloud
|
|
|
||
Materials from mixed absorption and model validation with VPCStarted by bwendt@certara.com , 24 May 2018 mixed absorption, VPC
|
|
|
||
Materials from NONMEM-NLME PD Emax inhibitory model with baseline and shapeStarted by bwendt@certara.com , 12 Jun 2018 NONMEM, PML, PD, Emax, Baseline and 1 more...
|
|
|
||
Materials from NONMEM-NLME session about nonlinear elimination model and bootstrapStarted by bwendt@certara.com , 24 May 2018 NONMEM, NLME, bootstrap
|
|
|
||
Materials from session about NONMEM-NLME Indirect Response with IV BolusStarted by bwendt@certara.com , 03 Jul 2018 NONMEM, PML, Inidrect
|
|
|
||
Materials from session about NONMEM-NLME PKPD 1comp-Emax,baseline,shape and effectStarted by bwendt@certara.com , 13 Jul 2018 NONMEM, NLME, PKPD, Emax, Effect
|
|
|
||
Materials from session about NONMEM-NLME: PD Categorical ResponseStarted by bwendt@certara.com , 23 Nov 2018 NONMEM, PML, NLME, Categorical
|
|
|
||
Materials from session about NONMEM-NLME: PD Count AnalysisStarted by bwendt@certara.com , 01 Apr 2019 NONMEM, PML, Count Analysis, PD
|
|
|
||
Materials from session about NONMEM-NLME: PD Time-to-event AnalysisStarted by bwendt@certara.com , 13 Dec 2018 NONMEM, PML, Time-to-event
|
|
|
||
minimal PBPK in PML with IV PO dosing why is F calculated for IV?Started by William R. Wolowich , 08 Jan 2019 PBPK IV PO dose F
|
|
|
||
Minimal physiologically-based pharmacokinetic model for monoclonal antibodiesStarted by bwendt@certara.com , 17 Nov 2017 mPBPK, PML, mAB
|
|
|
||
NONMEM-NLME Comparisons 1: Intro & 1-compartment IV Bolus FOCEStarted by bwendt@certara.com , 09 Feb 2018 NONMEM, PML, FOCE
|
|
|
||
NONMEM-NLME Comparisons: 2-compartment IV Bolus Multiple Dose Plasma UrineStarted by bwendt@certara.com , 23 Feb 2018 NONMEM, NLME, PML, Plasma, Urine and 3 more...
|
|
|
||
NONMEM-NLME Comparisons: 2-compartment oral with categorical covariateStarted by bwendt@certara.com , 08 Mar 2018 NONMEM, NLME, covariate and 1 more...
|
|
|
||
NONMEM-NLME Comparisons:TMDD Model translated from NONMEM (NM-TRAN) to Phoenix NLME (PML)Started by bwendt@certara.com , 22 Mar 2018 NONMEM, PML, TMDD
|
|
|
||
PML codes for a precursor modelStarted by mike.liu , 17 Jun 2020 PML, Coding, precursor model
|
|
|
||
PML learningStarted by nehabatra , 16 Dec 2016 |
|
|
||
PML School - Schedule for 2016Started by bwendt@certara.com , 14 Oct 2016 PML
|
|
|
||
PML School: Schedule for 2017Started by bwendt@certara.com , 19 Dec 2016 PML
|
|
|
||
Q&A from Adaptive Trial Simulation sessionStarted by bwendt@certara.com , 20 Dec 2017 PML, TSE, Adaptive Trial
|
|
|
||
Q&A from Intro-Session of NONMEM-NLME ComparisonsStarted by bwendt@certara.com , 10 Feb 2018 NONMEM, PML
|
|
|
||
Q&A from Lesson 10: Turnover III - Nonlinear DispositionStarted by bwendt@certara.com , 06 Mar 2017 PML, Turnover, Saturated
|
|
|
||
Q&A from Lesson 11: Analysis and comparison of a link, turnover and receptor binding modelStarted by bwendt@certara.com , 17 Mar 2017 PML, Link, Turnover, Receptor
|
|
|
||
Q&A from Lesson 12: Sigmoidal Response modelsStarted by Christopher Mehl , 03 Apr 2017 |
|
|
||
Q&A from Lesson 13: Modeling Tumor Growth/KillStarted by bwendt@certara.com , 18 Apr 2017 PML, Tumor Growth
|
|
|
||
Q&A from Lesson 14: Modeling Enzyme Inhibition by Means of TurnoverStarted by Christopher Mehl , 03 May 2017 Enzyme Inhibition, Turnover
|
|
|
||
Q&A from Lesson 15: Effect Compartment III - IV InfusionStarted by bwendt@certara.com , 21 Jun 2017 PML, Link, Effect compartment and 1 more...
|
|
|
||
Q&A from Lesson 16: Warfarin IV bolus Turnover modelsStarted by Christopher Mehl , 12 Jun 2017 |
|
|
||
Q&A from Lesson 19: Dose-response-time analysisStarted by bwendt@certara.com , 28 Jul 2017 Turnover, Bacterial Growth and 1 more...
|
|
|
